HEC-TV: St. Louis-Based C₂N Diagnostics has a Blood Test for Alzheimer’s Disease That’s Now in the Market

C₂N CEO Dr. Joel Braunstein explains in this video from HEC-TV Science & Technology that the company is “really the first group to introduce a blood test to the market to aid in the clinical diagnosis of Alzheimer's disease.”